Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients

In Japan, cetuximab with concurrent bioradiotherapy (BRT) for squamous cell carcinoma of head and neck (SCCHN) was approved in December 2012. We herein report our initial experience of BRT, with special emphasis on acute toxicities of this combination therapy. Thirty-one non-metastatic SCCHN patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Radiat Res
Asıl Yazarlar: Kurokawa, Marie, Watanabe Nemoto, Miho, Harada, Rintaro, Kobayashi, Hiroki, Horikoshi, Takuro, Kanazawa, Aki, Togasaki, Gentaro, Abe, Yukinao, Chazono, Hideaki, Hanazawa, Toyoyuki, Okamoto, Yoshitaka, Uno, Takashi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577007/
https://ncbi.nlm.nih.gov/pubmed/26160181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrv038
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller